SCHEMBL7653658

SCHEMBL7653658

O=C(NC(O)CCO)c1cncc(C(=O)NC(O)CCO)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.44
HPGD P15428 2/20 0.44
CASP3 P42574 4/20 0.42
ALDH1A1 P00352 3/20 0.42
HSD17B10 Q99714 2/20 0.42
USP2 O75604 1/20 0.41
TP53 P04637 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
XDH P47989 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
PTGS2 P35354 5/20 0.37
PTGS1 P23219 4/20 0.37
PRKACA P17612 1/20 0.37
CDK8 P49336 1/20 0.37
GSK3A P49840 1/20 0.37
GSK3B P49841 1/20 0.37
PRKX P51817 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7654705 0.80 KDM4E (0.40) KDM4EHPGDCASP3ALDH1A1HSD17B10
SCHEMBL6863197 0.79 KDM4E (0.33) KDM4EALDH1A1L3MBTL1POLBGAA
SCHEMBL7650766 0.79 CTSA (0.35) HPGD
SCHEMBL7653650 0.77 KDM4E (0.45) KDM4EHPGDCASP3ALDH1A1HSD17B10
SCHEMBL7658593 0.75 CNR2 (0.38) HPGDALDH1A1L3MBTL1POLBATM
SCHEMBL8501576 0.75 HPGD (0.50) HPGDALDH1A1HSD17B10ALOX15GAA
SCHEMBL7654698 0.75 KDM4E (0.44) KDM4EHPGDCASP3ALDH1A1HSD17B10
SCHEMBL7657510 0.74 ALDH1A1 (0.45) KDM4EALDH1A1POLB
SCHEMBL6864033 0.74 GAA (0.47) ALDH1A1GAA
SCHEMBL7660893 0.73 KDM4E (0.47) KDM4EHPGDCASP3ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US disclosed